The cost of treating genital warts

Michael J. Strauss, Vikram Khanna, Jacqueline D. Koenig, Stephen Downs, Steven H. Goldberg, Michael J. Manyak, Bruce Patsner

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Background. Genital warts is a common sexually transmitted disease treated by a variety of medical specialists. Standard therapies offer symptomatic relief but cannot ensure lasting remission. Using the clinical literature, claims databases, and a panel of experienced practitioners, the relative efficacy, cost and cost effectiveness of five common treatments for genital warts were assessed in this study. Methods. We reviewed the clinical literature for the following genital wart therapies: podofilox, podophyllin, trichloroacetic acid, cryotherapy, and laser therapy, focusing on their relative efficacy. Physicians experienced in treating genital warts defined standard treatment protocols for men and women patients with moderate wart burdens. Using national claims data and protocols developed by physicians, we derived three economic models based on provider charges, third-party payments, and a resource-based relative value scale, respectively. Results. The literature review demonstrated highly variable success and recurrence rates among treatment methods and failed to show that one treatment provides consistently superior efficacy. In the economic models, treating women generally proved more costly than treating men per episode of care. This was due to the need for more extensive follow-up visits in the treatment of women. Total costs were highest fore cryotherapy and lowest for a patient-applied therapy that reduced the need for follow-up visits. Conclusions. Clinicians should consider both clinical and cost issues when choosing the appropriate treatment for patients with genital warts.

Original languageEnglish (US)
Pages (from-to)340-348
Number of pages9
JournalInternational Journal of Dermatology
Volume35
Issue number5
StatePublished - May 1996
Externally publishedYes

Fingerprint

Condylomata Acuminata
Costs and Cost Analysis
Economic Models
Cryotherapy
Therapeutics
Relative Value Scales
Podophyllin
Episode of Care
Podophyllotoxin
Health Insurance Reimbursement
Physicians
Trichloroacetic Acid
Warts
Laser Therapy
Clinical Protocols
Sexually Transmitted Diseases
Cost-Benefit Analysis
Databases
Recurrence

ASJC Scopus subject areas

  • Dermatology

Cite this

Strauss, M. J., Khanna, V., Koenig, J. D., Downs, S., Goldberg, S. H., Manyak, M. J., & Patsner, B. (1996). The cost of treating genital warts. International Journal of Dermatology, 35(5), 340-348.

The cost of treating genital warts. / Strauss, Michael J.; Khanna, Vikram; Koenig, Jacqueline D.; Downs, Stephen; Goldberg, Steven H.; Manyak, Michael J.; Patsner, Bruce.

In: International Journal of Dermatology, Vol. 35, No. 5, 05.1996, p. 340-348.

Research output: Contribution to journalArticle

Strauss, MJ, Khanna, V, Koenig, JD, Downs, S, Goldberg, SH, Manyak, MJ & Patsner, B 1996, 'The cost of treating genital warts', International Journal of Dermatology, vol. 35, no. 5, pp. 340-348.
Strauss MJ, Khanna V, Koenig JD, Downs S, Goldberg SH, Manyak MJ et al. The cost of treating genital warts. International Journal of Dermatology. 1996 May;35(5):340-348.
Strauss, Michael J. ; Khanna, Vikram ; Koenig, Jacqueline D. ; Downs, Stephen ; Goldberg, Steven H. ; Manyak, Michael J. ; Patsner, Bruce. / The cost of treating genital warts. In: International Journal of Dermatology. 1996 ; Vol. 35, No. 5. pp. 340-348.
@article{dfb2c604b4e84eaa8077b35646d9d47f,
title = "The cost of treating genital warts",
abstract = "Background. Genital warts is a common sexually transmitted disease treated by a variety of medical specialists. Standard therapies offer symptomatic relief but cannot ensure lasting remission. Using the clinical literature, claims databases, and a panel of experienced practitioners, the relative efficacy, cost and cost effectiveness of five common treatments for genital warts were assessed in this study. Methods. We reviewed the clinical literature for the following genital wart therapies: podofilox, podophyllin, trichloroacetic acid, cryotherapy, and laser therapy, focusing on their relative efficacy. Physicians experienced in treating genital warts defined standard treatment protocols for men and women patients with moderate wart burdens. Using national claims data and protocols developed by physicians, we derived three economic models based on provider charges, third-party payments, and a resource-based relative value scale, respectively. Results. The literature review demonstrated highly variable success and recurrence rates among treatment methods and failed to show that one treatment provides consistently superior efficacy. In the economic models, treating women generally proved more costly than treating men per episode of care. This was due to the need for more extensive follow-up visits in the treatment of women. Total costs were highest fore cryotherapy and lowest for a patient-applied therapy that reduced the need for follow-up visits. Conclusions. Clinicians should consider both clinical and cost issues when choosing the appropriate treatment for patients with genital warts.",
author = "Strauss, {Michael J.} and Vikram Khanna and Koenig, {Jacqueline D.} and Stephen Downs and Goldberg, {Steven H.} and Manyak, {Michael J.} and Bruce Patsner",
year = "1996",
month = "5",
language = "English (US)",
volume = "35",
pages = "340--348",
journal = "International Journal of Dermatology",
issn = "0011-9059",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - The cost of treating genital warts

AU - Strauss, Michael J.

AU - Khanna, Vikram

AU - Koenig, Jacqueline D.

AU - Downs, Stephen

AU - Goldberg, Steven H.

AU - Manyak, Michael J.

AU - Patsner, Bruce

PY - 1996/5

Y1 - 1996/5

N2 - Background. Genital warts is a common sexually transmitted disease treated by a variety of medical specialists. Standard therapies offer symptomatic relief but cannot ensure lasting remission. Using the clinical literature, claims databases, and a panel of experienced practitioners, the relative efficacy, cost and cost effectiveness of five common treatments for genital warts were assessed in this study. Methods. We reviewed the clinical literature for the following genital wart therapies: podofilox, podophyllin, trichloroacetic acid, cryotherapy, and laser therapy, focusing on their relative efficacy. Physicians experienced in treating genital warts defined standard treatment protocols for men and women patients with moderate wart burdens. Using national claims data and protocols developed by physicians, we derived three economic models based on provider charges, third-party payments, and a resource-based relative value scale, respectively. Results. The literature review demonstrated highly variable success and recurrence rates among treatment methods and failed to show that one treatment provides consistently superior efficacy. In the economic models, treating women generally proved more costly than treating men per episode of care. This was due to the need for more extensive follow-up visits in the treatment of women. Total costs were highest fore cryotherapy and lowest for a patient-applied therapy that reduced the need for follow-up visits. Conclusions. Clinicians should consider both clinical and cost issues when choosing the appropriate treatment for patients with genital warts.

AB - Background. Genital warts is a common sexually transmitted disease treated by a variety of medical specialists. Standard therapies offer symptomatic relief but cannot ensure lasting remission. Using the clinical literature, claims databases, and a panel of experienced practitioners, the relative efficacy, cost and cost effectiveness of five common treatments for genital warts were assessed in this study. Methods. We reviewed the clinical literature for the following genital wart therapies: podofilox, podophyllin, trichloroacetic acid, cryotherapy, and laser therapy, focusing on their relative efficacy. Physicians experienced in treating genital warts defined standard treatment protocols for men and women patients with moderate wart burdens. Using national claims data and protocols developed by physicians, we derived three economic models based on provider charges, third-party payments, and a resource-based relative value scale, respectively. Results. The literature review demonstrated highly variable success and recurrence rates among treatment methods and failed to show that one treatment provides consistently superior efficacy. In the economic models, treating women generally proved more costly than treating men per episode of care. This was due to the need for more extensive follow-up visits in the treatment of women. Total costs were highest fore cryotherapy and lowest for a patient-applied therapy that reduced the need for follow-up visits. Conclusions. Clinicians should consider both clinical and cost issues when choosing the appropriate treatment for patients with genital warts.

UR - http://www.scopus.com/inward/record.url?scp=0029930767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029930767&partnerID=8YFLogxK

M3 - Article

VL - 35

SP - 340

EP - 348

JO - International Journal of Dermatology

JF - International Journal of Dermatology

SN - 0011-9059

IS - 5

ER -